An improved understanding of pathogenic pathways may identify novel acute kidney injury (AKI) therapeutic approaches. Unbiased LC-MS/MS protein expression profiling combined with focused data mining identified MAP3K14 and non-canonical NFκB activation at the crossroads of the enriched pathways MAPK, ubiquitin-mediated proteolysis, chemokines, NFκB and apoptosis in the kidney cortex of experimental toxic AKI. In AKI the upstream kinase MAP3K14, the NFκB DNA binding heterodimer RelB/NFκB2, and proteins involved in NFκB2 p100 ubiquitination and proteasomal processing to p52, such as Ube2m and cullin1 were up-regulated. Immunohistochemistry localized MAP3K14 expression to tubular cells in experimental and human AKI. In vivo evidence of MAP3K14 activation in experimental folic acid-induced AKI consisted of NFκB2 p100 processing to p52, nuclear location and DNA binding of RelB and NFκB2. MAP3K14 activity-deficient aly/aly mice were protected from kidney dysfunction, inflammation and apoptosis in AKI induced by folic acid and from lethality in cisplatin-induced AKI. 
INTRODUCTION
The incidence of acute kidney injury (AKI) is increasing 1 . However, there is currently no therapy that reliably prevents the progression to AKI or accelerates recovery of renal function 2;3 . Thus, reliable biomarkers and novel therapeutic approaches are needed 4 . AKI is characterized by kidney inflammation and tubular cell death, dedifferentiation and subsequent proliferation [5] [6] [7] [8] [9] . However, given the complexity and redundancies of the process, it is unlikely that targeting a single inflammatory molecule provides the kind of benefit that will be clinically relevant. Thus, attention has focused on upstream signaling pathways that may regulate the coordinated expression of an array of inflammatory molecules. The combination of unbiased protein expression profiling with focused data mining is a powerful tool to expand our knowledge of relevant pathways and key factors in disease. Liquid chromatography tandem mass spectrometry (LC-MS/MS) identified ~2,000 proteins in murine renal cortex 10 . However, its applications to the study of AKI has been limited and mainly concentrated in the analysis of biofluids such as urine or in the study of the metabolome rather than the proteome [11] [12] [13] [14] . To identify novel pathways and mediator networks active in AKI in a comprehensive manner, we used tissue
LC-MS/MS to assess changes in the renal proteome of experimental toxic AKI. Bioinformatics analysis of 41235 peptides in cortical kidney tissue by LC-MS/MS proteomics allowed the identification of 6516
unique proteins, of which 1480 were differentially expressed in samples from experimental nephrotoxic AKI as compared with controls 15 . On this previously reported raw dataset, we have now performed novel pathway analysis in search of cell death or inflammatory pathways that are activated in AKI. This analysis indicated enrichment of proteins from the non-canonical activation pathway for transcription factor nuclear factor kappa-B (NFκB). NFκB promotes inflammation by modulating gene transcription 16;17 . Canonical NFκB activation is rapidly initiated through degradation of IκB proteins by the proteasome, thus releasing complexes that translocate to the nucleus to promote transcription of proinflammatory genes and downregulate the expression of anti-inflammatory molecules such as Klotho 18;19 .
By contrast, non-canonical NFκB activation is a delayed response that is engaged by a limited number of stimuli and involves activation of the mitogen-activated protein kinase kinase kinase 14 (MAP3K14)/NFκB-inducing kinase (NIK), proteasomal processing of NFκB p100 to p52 and nuclear translocation of p52/RelB complexes 16;20 . The role and regulation of MAP3K14 in AKI is poorly understood.
The combined proteomic and bioinformatics approach enabled identification of evidence for MAP3K14 activation and the upregulation of several proteins of the non-canonical NFκB activation pathway in AKI that were confirmed by Western blot and immunohistochemistry. Functional studies identified chemokine expression and cell death and proliferation as novel MAP3K14-regulated processes in tubular cells. Furthermore, MAP3K14 was overexpressed during human AKI and genetically modified mice confirmed the key role of MAP3K14 in AKI.
RESULTS

Kidney tissue proteomics bioinformatics analysis identifies upregulation of MAP3K14 and noncanonical NFκB components in AKI
Experimental AKI is characterized by increased serum creatinine (0.53±0.25 vs 0.10±0.02 mg/dl at 24h, p<0.05), tubular cell death and interstitial inflammation 15 . As previously described, unbiased proteomics combined with focused data analysis was conducted in 24h kidney cortex control and AKI samples 15 . LC-MS/MS identified 41235 peptides in the kidney cortex corresponding to 6516 unique nonredundant, proteins (Supplementary Figure 1) 15 . The present study represents a new complimentary analysis of this previously generated dataset. KEGG pathway analysis identified the enrichment of several pathways based on the up-regulation of key proteins in AKI samples ( Table 1) . NFκB was at the crossroads of several of these pathways. NFκB activation is regulated by MAPK, requires ubiquitination and proteasomal processing or degradation, and regulates apoptosis and chemokine secretion. Canonically activated NFκB signaling has long been implicated in kidney injury 16 . However, there is much less information on non-canonical NFκB activation and its components. A targeted data mining approach searched for components of the non-canonical NFκB pathway. A KEGG generated NFκB signaling pathway map (Supplementary Figure 2) summarizes the expression of non-canonical NFκB signaling pathway components and of NFκB2 (p100/p52) ubiquitination and proteasomal activation. Upregulation was observed for MAP3K14, the essential upstream kinase activating the non-canonical NFκB pathway 21;22 , for proteins required for NFκB2 p100 ubiquitination and proteasomal processing to active NFκB2 p52, such as Ube2m/Ubc12 (E2) and cullin-1 (E3), and for the two main components of non-canonical NFκB DNA-binding heterodimers, NFκB2 and RelB ( Table 2) .
Validation of non-canonical NFκB pathway activation in AKI
The proteomics findings of increased MAP3K14, RelB and NFκB2 p100/p52 were validated by Western blot and immunohistochemistry and the mechanisms by which the system is up-regulated were explored by assessing mRNA expression. Kidney MAP3K14, RelB and NFκB2 mRNA expression was increased in AKI, suggesting transcriptional up-regulation (Figure 1.A, 2 .A, 2.C). Western blot confirmed increased kidney MAP3K14, RelB, NFκB2 p100 and NFκB2 p52 in AKI (Figure 1.B, 2 .B,
2.D, 2.E).
Immunohistochemistry localized the increased expression of these proteins to tubular cells (Figure 1.C) . In addition, NFκB2 p52 and RelB DNA-binding activity was increased in nuclear extracts from AKI kidneys (Figure 2.F) . Thus, evidence for increased activation of MAP3K14 includes processing of NFκB2 p100 to NFκB2 p52 and nuclear translocation and increased DNA binding activity of the RelB/NFκB2 p52 transcription factor. The expression of the ubiquitination pathway Cullin-1 protein was also confirmed to be increased in AKI (Supplementary Figure 3) .
Given the poor understanding of its role in kidney injury and its upstream situation in the pathway, we further explored the role of MAP3K14 in AKI. In this regard, extensive MAP3K14
immunostaining was also observed in kidney tubules in human AKI (Figure 3 ).
MAP3K14 deficient mice were protected from AKI
To explore the role of MAP3K14 in AKI, we used MAP3K14 activity-deficient alymphoplasia (MAP3K14 aly/aly ) mice, which carry a point mutation causing an amino acid substitution in the carboxyterminal interaction domain of MAP3K14 23;24 . MAP3K14 +/aly heterozygote mice and MAP3K14 +/+ mice were used as controls. Immunohistochemistry confirmed the lack of RelB (Fig 5.A) and NFκB2 p52 expression in MAP3K14 deficient mice with AKI (Fig 5.B) and disclosed decreased F4/80 macrophages and CD3 T lymphocytes (Fig. 6.A and B) and TUNEL positive tubular cells representing dying cells (Fig 6.C 
MAP3K14 function in tubular cells
Following the findings of MAP3K14 upregulation and of evidence for MAP3K14 activation NFκB is a family of structurally homologous proteins, including NFκB1, NFκB2, RelA, RelB, and c-Rel, which form homo-or hetero-dimers that bind to κB enhancers in DNA to promote or inhibit gene transcription 16 . Two main pathways for NFκB activation are known. Canonical NFκB activation is usually a rapid, protein synthesis-independent and transient response to a wide range of stimuli that involves proteasomal degradation of cytosolic IκB inhibitory proteins leading to the release of RelA/p50
and other dimers that then migrate to the nucleus. NFκB-driven IκBα re-synthesis contributes to a fast turn-off of the response. By contrast, non-canonical NFκB activation requires MAP3K14 activation and NFκB2 p100 processing to p52 by the proteasome, resulting in a delayed nuclear translocation of RelB/p52 heterodimers and in prolonged activation of NFκB target genes [31] [32] [33] . Increased transcription of NFκB2 and RelB may contribute to persistence of the response 34 . By contrast to the canonical pathway, only a limited number of stimuli are known to activate the non-canonical NFκB pathway. These include advanced glycosylation end-products 33 There is evidence for a role of canonical activation of NFκB in kidney injury 16 . However, no therapeutic approach specifically targeting NFκB systemically is undergoing clinical trials, suggesting a fundamental lack of understanding of the system. In this regard, the role of MAP3K14 and non-canonical NFκB activation in AKI has not been well characterized. There is very little and scattered information on activation of this pathway in kidney disease. MAP3K14 was phosphorylated in tubular cells during kidney ischemia-reperfusion 40 and levels were increased in experimental diabetic nephropathy and human delayed graft function 40;41 . TWEAK-dependent nuclear translocation of RelB and p52 was observed in tubular cells in nephrotoxic AKI 25 . In the present report, kidney tissue proteomics identified upregulation of several proteins in the non-canonical NFκB pathway, upregulation of these proteins was confirmed and localized to tubular cells, the contribution of transcriptional regulation was identified and the role of MAP3K14 in tubular cell injury was characterized. In this regard, MAP3K14 activity deficient mice were protected from AKI. Thus, MAP3K14 represents a key regulated step promoting AKI that may potentially be subject to therapeutic manipulation, although at present there are no satisfactory MAP3K14 inhibitors 42 .
MAP3K14 is the essential upstream serine/threonine kinase of the non-canonical NFκB pathway that binds to TRAF2 and participates in NFκB signaling in response to the TNF superfamily and interleukin 1 receptors. 22 . MAP3K14 protein concentrations are low in quiescent cells as a result of rapid degradation. Cytokines and oxidative stress may increase MAP3K14 protein stability, leading to MAP3K14 activation 20 . In addition to this universal mechanism of MAP3K14 regulation, we now found increased steady-state MAP3K14 mRNA levels as an additional regulatory mechanism of MAP3K14 expression in tubular epithelium that also takes place in vivo during AKI. MAP3K14 induces IκB kinase-α (IKK-α)-mediated phosphorylation of NFκB2 p100, a prerequisite for p100 ubiquitination and subsequent proteasomal processing to active NFκB2 p52 32 .
Ubiquitination is required for targeting of specific proteins to the proteasome. F-box proteins provide specificity for substrate recognition in the S-phase kinase associated protein 1 (SKP1)-cullin 1 (CUL1)-F-box protein (SCF) family of the Cullin-RING ligases (CRL) E3 ubiquitin ligase superfamily 43 .
The F-box protein β-transducin repeat containing (β-TrCP; FBW1A) provides substrate specificity for MAP3K14-phosphorylated p100, allowing ubiquitination by SCF β-TrCP 44-47 . Efficient NFκB2 p100 ubiquitination requires Uba3 (ube1c) and Ube2m (UBC12), ube2d3 (UBCH5c) and intact Cullin1 in SCF β-TrCP 45 . Interestingly, the Ube2m E2 ubiquitin conjugating enzyme and cullin-1 of the SCF β -TrCP E3 ubiquitin ligase were found to be upregulated in AKI.
Evidence for MAP3K14 activation in vivo in AKI included increased MAP3K14 levels, NFκB p100 processing to NFκB p52, increased nuclear localization and DNA binding activity of p52/RelB and decreased kidney inflammation and cell death and preserved renal function in MAP3K14 activity deficient mice. Protection from AKI may depend on systemic MAP3K14 deficiency (e.g. leukocyte NFκB activation is delayed and peaks at around 24h, non-canonical NFκB activation by contribute to sustained NFκB-dependent gene expression 16;28;48 . In this regard, the CC genotype of the MAP3K14 SNP rs7222094 was recently associated with increased mortality and renal dysfunction in septic shock patients 26 . CXCL10 was the gene with the greatest difference in expression between major and minor MAP3K14
genotypes. The rs7222094 genotype strongly associated with decreased CXCL10 levels in lymphoblastoid cell lines and in septic shock patients 26 . Urinary CXCL10 is increased in AKI patients 49;50 and, as shown here, in AKI kidney tissue. We now provide for the first time direct functional evidence that persistent CXCL10 expression in response to TWEAK is regulated by MAP3K14. CXCL10
(IP-10) had long been associated to kidney injury in animals and humans 51;52 . MCP-1 and RANTES, which are targets of canonical NFκB activation 53 were also found to be MAP3K14-dependent in tubular cells. CCL21a was previously shown to be MAP3K14-dependent in this cell system 27 
Materials and methods
Animal model
Studies were conducted in accord with the NIH Guide for the Care 
Sample preparation and mass spectrometry analysis
Tissue samples were weighed out and extracted using the Filter Aided Sample Preparation (FASP) method 60 , as described previously 15 . Briefly, tissue samples were homogenised in SDS-lysis SEQUEST, only peptides that showed mass deviation of less than 10 ppm were passed, the peptide data were extracted using high peptide confidence and top one peptide rank filters. Statistical p-value analysis was performed using the Wilcoxon Mann Whitney test.
Bioinformatics analysis
Protein identification and a significant dataset of 1480 entries with p-values <0.05 and fold changes of >2 have been previously described 15 . This dataset was used for metabolic and signaling pathway analysis using the KEGG web-resource (www.genome.jp/kegg-bin/) or with PathVisio (www.pathvisio.org). Focused data mining was then amplified to all molecules with a p-value≤0.05.
Cells and reagents
MCT cells are a cultured line of proximal tubular epithelial cells harvested originally from the renal cortex of SJL mice and have been extensively characterized 61 . MCT cells were cultured in RPMI 1640 (GIBCO, Grand Island, NY, USA), 10% decomplemented fetal bovine serum (FBS), 2 mM glutamine, 100 U/ml penicillin and 100 µg/ml streptomycin, in 5% CO2 at 37 ºC 61 . Recombinant human soluble TWEAK (Millipore, Billerica, MA) was used at 100 ng/ml.
Western blot analysis
Tissue and cell samples were homogenized in lysis buffer 62 and levels of expression were corrected for minor differences in loading.
Quantitative reverse transcription-polymerase chain reaction
One µg RNA isolated by Trizol (Invitrogen, Paisley, UK) was reverse transcribed with High Capacity cDNA Archive Kit and real-time PCR was performed on a ABI Prism 7500 PCR system (Applied Biosystems, Foster City, CA) using the DeltaDelta Ct method 63 . Expression levels are given as ratios to GAPDH. Pre-developed primer and probe assays were from Applied Biosystems, Foster City, CA.
Immunohistochemistry
Immunohistochemistry was carried out as previously described on paraffin-embedded 5 µm thick tissue sections 62 . Primary antibodies were rabbit polyclonal anti-RelB (1:50, Santa Cruz, CA, USA), anti-NFκB2 p100/p52 (1:20, Santa Cruz, CA, USA), anti-MAP3K14 (1:100, Cell Signaling), rat polyclonal anti-F4/80 antigen (1:50; Serotec, Oxford, UK), rabbit monoclonal anti-CD3 (1:100, Dako, Denmark) and anti-Cullin-1 (1:80, Santa Cruz, CA, USA). Sections were counterstained with Carazzi`s hematoxylin.
Negative controls included incubation with a non-specific immunoglobulin of the same isotype as the primary antibody.
Apoptosis was assayed by deoxynucleotidyl-transferase-mediated dUTP nick-end labeling (TUNEL) (In Situ Cell Death Detection Kit; Roche) according to the manufacturer's instructions 63 .
For human kidney immunohistochemistry, control kidney tissue from nephrectomy specimens (n=4) and AKI tissue (n=7) diagnosed as "acute tubular necrosis" was studied. Mean age was 36-4±18.6
years, four patients were females and serum creatinine ranged from 1.7 to 10.0 mg/dl (5.7±3.5 mg/dl).
Immunohistochemistry was performed as described above by using anti-human MAP3K14 from Abcam.
Transfection with small interfering RNA
Cells were grown in six-well plates (Costar, Cambridge, MA) and transfected with a mixture of 20 nmol/mL MAP3K14 siRNA (Santa Cruz, CA, USA), Opti-MEM I Reduced Serum Medium and Lipofectamine 2000 (Invitrogen) 64 . After 18 hours, cells were washed and cultured for 6 hours in complete medium, and serum-depleted for 24 h before addition of stimulus. This time point was selected from a time-course of decreasing MAP3K14 protein expression in response to siRNA. A negative control scrambled siRNA provided by the manufacturer did not reduce MAP3K14 protein.
Cell death and apoptosis
Cells were cultured to subconfluence in six-well plates and transfected with MAP3K14 siRNA as previously described 65 . Apoptosis was assessed by flow cytometry of DNA content. For assessment of the cell cycle and apoptosis, adherent cells were pooled with spontaneously detached cells, and stained in permeabilizes the cells. Permeabilization allows entry of propidium iodide into all cells, dead or alive.
Apoptotic cells are characterized by a lower DNA content (hypodiploid cells) because of nuclear fragmentation. Thus, this assay is not based on the known ability of propidium iodide to enter dead cells.
The percentage of apoptotic cells with decreased DNA content (A o ) was counted 30 .
ELISA
Cells were transfected with MAP3K14 siRNA and stimulated with 100 ng/ml TWEAK. Murine CxCL10 in the supernatants was determined by ELISA (BD Pharmingen, San Diego, CA).
NFκB DNA-binding activity
RelB and NFκB2 p52 subunits in nuclear extracts from kidney tissue were assessed by their binding to an oligonucleotide containing the NFκB consensus site using TransAM NFκB Family Kit (Active Motif, Carlsbad, CA).
Statistics
Statistical analysis was performed using SPSS 11.0 statistical software (IBM, NY, USA). Results are expressed as mean ± SD. Significance at the p<0.05 level was assessed by Student´s t test for two groups of data and ANOVA for three of more groups. 
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